- Home
- ROIV vs DBX Comparison
ROIV vs DBX Comparison
Compare ROIV & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | DBX |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United Kingdom | United States |
| Employees | 721 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 6.9B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ROIV | DBX |
|---|---|---|
| Price | $35.82 | $32.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 8 |
| Target Price | ★ $28.94 | $28.14 |
| AVG Volume (30 Days) | ★ 8.7M | 4.2M |
| Earning Date | 05-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.86 |
| EPS | N/A | ★ 0.91 |
| Revenue | ★ $8,260,000.00 | N/A |
| Revenue This Year | N/A | $0.20 |
| Revenue Next Year | $744.61 | N/A |
| P/E Ratio | ★ N/A | $35.89 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.86 | $21.70 |
| 52 Week High | $42.50 | $38.17 |
Technical Indicators
Market Signals| Indicator | ROIV | DBX |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 37.71 |
| Support Level | $33.15 | $24.40 |
| Resistance Level | $37.12 | $36.33 |
| Average True Range (ATR) | 1.45 | 1.26 |
| MACD | -0.52 | -0.56 |
| Stochastic Oscillator | 4.15 | 1.76 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.